MAM
WVE icon

Martingale Asset Management’s Wave Life Sciences WVE Stock Holding History

Martingale Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,252
Closed -$119K – 851
2025
Q3 		$119K Sell
16,252
-14,160
-47% -$115K ﹤0.01% 749
2025
Q2 		$198K Sell
30,412
-5,300
-15% -$35K ﹤0.01% 759
2025
Q1 		$289K Buy
35,712
+25,412
+247% +$278K 0.01% 683
2024
Q4 		$127K Sell
10,300
-100,899
-91% -$1.35M ﹤0.01% 750
2024
Q3 		$912K Buy
111,199
+22,652
+26% +$135K 0.02% 480
2024
Q2 		$442K Buy
88,547
+19,643
+29% +$112K 0.01% 625
2024
Q1 		$425K Buy
68,904
+97
+0.1% +$486 0.01% 645
2023
Q4 		$347K Buy
68,807
+25,190
+58% +$135K 0.01% 677
2023
Q3 		$251K Buy
+43,617
New +$199K 0.01% 717
2020
Q4 		– Sell
-62,713
Closed -$533K – 1054
2020
Q3 		$533K Sell
62,713
-77,600
-55% -$851K 0.01% 796
2020
Q2 		$1.46M Buy
+140,313
New +$1.32M 0.02% 627

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Martingale Asset Management's WVE Position: Q4 2025 in Review

Martingale Asset Management sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 16,252 shares — an estimated $119K sold.

Martingale Asset Management first reported a position in WVE in Q2 2020 and held it in 11 quarters. The position peaked at $1.46M in Q2 2020. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Martingale Asset Management reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Martingale Asset Management sold 16,252 Wave Life Sciences shares in Q4 2025, an estimated $119K.
  • Martingale Asset Management first reported a position in Wave Life Sciences in Q2 2020 and held it in 11 quarters.
  • Martingale Asset Management's Wave Life Sciences position peaked at $1.46M in Q2 2020.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Martingale Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.